Third quarter results 2025 HIGHLIGHTS Q3 EBITDA of USD 43.9 million and operating cashflow of USD 142.0 millionRobust balance sheet with USD 624 million in available liquidityQ3 cash dividend of USD 0 ...
Treatment Market is projected to grow at a healthy rate of around 13% by 2026. This growth is primarily driven by the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈